A Washington judge has ordered Albertsons Companies and its Safeway subsidiary to pay $900 million after finding that their pharmacies helped fuel the state’s opioid crisis by filling millions of prescriptions that carried warning signs of misuse or diversion without documented checks, Reuters reported on November 5, 2026. This is other parties’ case, not a Tacher Law case. The ruling came after a trial, and Albertsons says it disagrees with it and is evaluating an appeal.

According to Reuters and the Washington Attorney General’s Office, the State of Washington sued Albertsons and other pharmacy companies in 2022 in King County Superior Court in Seattle (State of Washington v. Rite Aid Corp. et al., No. 22-2-20910-1 SEA). By the time of trial, every other defendant had settled or been dismissed, leaving Albertsons as the only defendant. Judge Janet Helson heard the case without a jury over nine weeks, from July 13 to September 14, 2026, and issued 219 pages of findings of fact and conclusions of law with the final judgment on November 5, 2026.

The court found that between 2006 and 2022, Albertsons pharmacies dispensed more than 641 million opioid pills in Washington, and that more than 6.5 million opioid prescriptions — over 60 percent of the total — triggered at least one recognized “red flag” of diversion without documented resolution. The court also found that Albertsons, acting as a distributor to its own stores, never reported a single suspicious order to the Drug Enforcement Administration, and that understaffing contributed to the failures. On those findings, the judge held Albertsons liable for creating and maintaining a public nuisance and for violating Washington’s Consumer Protection Act.

The $900 million judgment has two parts: $800 million to fund a court-supervised opioid abatement plan — treatment, prevention, and harm reduction — and $100 million in civil penalties, plus the state’s costs and attorneys’ fees. If the abatement award is reduced or overturned, the penalty rises to $337,921,650 under the judgment. The state had asked for $2.2 billion in abatement at closing. Albertsons denied wrongdoing. Its lawyers argued at trial that it sold legal drugs prescribed by doctors and that pharmacists should not second-guess a doctor without a real reason to suspect a prescription was illegitimate; in a statement after the ruling, the company said it is disappointed, respectfully disagrees with the conclusions, and will evaluate all options, including an appeal. For context, Albertsons announced a $774 million settlement in April 2026 resolving most opioid claims against it nationwide — Washington declined to join that deal and took its case to trial instead.

Sources: Reuters, November 5, 2026; Corporate INTL summary of the King County findings of fact and conclusions of law, November 5–6, 2026.

What this ruling shows about pharmacy red-flag duties — and the Florida comparison

The legal lesson is about documentation. The Washington court’s penalty was counted prescription by prescription, from the pharmacy chain’s own dispensing records: a red flag that is seen but not resolved and documented is, in the court’s view, a violation. That principle matters well beyond opioids. In an individual pharmacy-error case — a wrong drug, a wrong dose, a dangerous interaction that should have been caught — the dispensing record, the warning the system generated, and what the pharmacist did about it are usually the evidence that decides the claim. If a pharmacy’s mistake harmed you, keep the bottle, the paperwork, and every receipt, and do not assume the store’s own account is the whole record.

This is a Washington case decided under Washington law, and it is not a Florida ruling. The Florida comparison is only a comparison: Florida has its own consumer-protection law, the Florida Deceptive and Unfair Trade Practices Act (Fla. Stat. § 501.204), and Florida pharmacy negligence claims are individual injury claims with their own rules. As general background, Florida negligence claims follow modified comparative negligence — recovery is reduced by the injured person’s percentage of fault and barred entirely if that person is more than 50% at fault — while medical malpractice claims are the exception and still follow pure comparative negligence under Chapter 766. A government abatement judgment like Washington’s is a different kind of case from an injured person’s claim for damages, and the $900 million figure is not a prediction of any individual recovery.

Disclaimer: This report concerns other parties’ cases. It is news reporting and general information, not legal advice. The judgment described is a trial-court ruling that the defendant says it may appeal, and past results in other cases do not guarantee similar outcomes.

Tacher Law
16445 Collins Avenue, Suite 1625, Sunny Isles Beach, FL 33160
+1 (305) 644-2211

Did a pharmacy’s mistake hurt you or someone in your family? Contact Tacher Law for a free consultation or call +1 (305) 644-2211.